EMA OKs Seven New Drugs Including First RSV Vaccine For Older Adults

 
• By Neena Brizmohun

GSK’s Arexvy vaccine for preventing lower respiratory tract disease caused by respiratory syncytial virus in adults aged 60 years and older is among the latest products that the European Medicines Agency said should be approved for use in the EU.

RSV virus
The first respiratory syncytial virus vaccine for older adults could be approved in the EU soon • Source: Shutterstock

More from Europe

More from Geography